RecruitingPhase 3NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Hartford, CT · +45 more sites
5 recruiting prostate cancer studies with a site in Hartford, CT.
Sponsor: Amgen
Hartford, CT · +45 more sites
Sponsor: Janssen Research & Development, LLC
Hartford, CT · +53 more sites
Sponsor: Novartis Pharmaceuticals
Hartford, CT · +34 more sites
Sponsor: City of Hope Medical Center
Hartford, CT · +9 more sites
Sponsor: SWOG Cancer Research Network
Derby, CT · Fairfield, CT · Glastonbury, CT · +130 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.